We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| ThermoGenesis Holdings Inc | NASDAQ:THMO | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.0162 | -2.36% | 0.67 | 0.61 | 0.99 | 0.71 | 0.6668 | 0.70 | 25,624 | 05:00:03 |
From May 2023 to May 2024
RANCHO CORDOVA, Calif., Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET, during the H.C. Wainwright 25th Annual Global Investment Conference, taking place September 11-13, 2023, in New York.
Dr. Xu will also host in-person and virtual one-on-one meetings during the event. Institutional investors who are registered for the conference can log into www.hcwevents.com to request a meeting with the company. Those interested in meeting with Dr. Xu outside of the conference should contact Michael Miller at mmiller@rxir.com.
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.
Contact Information
Company Contact:
Wendy Samford
916-858-5191
ir@thermogenesis.com
Investor Relations Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com
View original content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-present-at-the-hc-wainwright-25th-annual-global-investment-conference-301918883.html
SOURCE ThermoGenesis Holdings, Inc.
Copyright 2023 PR Newswire
1 Year ThermoGenesis Chart |
1 Month ThermoGenesis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
